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Background: Mesenchymal stromal cells (MSCs) and Ophiophagus hannah L-amino acid oxidase (Oh-LAAO) have
been reported to exhibit antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). Published
data have indicated that synergistic antibacterial effects could be achieved by co-administration of two or more
antimicrobial agents. However, this hypothesis has not been proven in a cell- and protein-based combination. In
this study, we investigate if co-administration of adipose-derived MSCs and Oh-LAAO into a mouse model of
MRSA-infected wounds would be able to result in a synergistic antibacterial effect.
Methods: MSCs and Oh-LAAO were isolated and characterized by standard methodologies. The effects of the
experimental therapies were evaluated in C57/BL6 mice. The animal study groups consisted of full-thickness
uninfected and MRSA-infected wound models which received Oh-LAAO, MSCs, or both. Oh-LAAO was administered
directly on the wound while MSCs were delivered via intradermal injections. The animals were housed individually
with wound measurements taken on days 0, 3, and 7. Histological analyses and bacterial enumeration were
performed on wound biopsies to determine the efficacy of each treatment.
Results: Immunophenotyping and differentiation assays conducted on isolated MSCs indicated expression of
standard cell surface markers and plasticity which corresponds to published data. Characterization of Oh-LAAO by
proteomics, enzymatic, and antibacterial assays confirmed the identity, purity, and functionality of the enzyme prior
to use in our subsequent studies. Individual treatments with MSCs and Oh-LAAO in the infected model resulted in
reduction of MRSA load by one order of magnitude to the approximate range of 6 log10 colony-forming units
(CFU) compared to untreated controls (7.3 log10 CFU). Similar wound healing and improvements in histological
parameters were observed between the two groups. Co-administration of MSCs and Oh-LAAO reduced bacterial
burden by approximately two orders of magnitude to 5.1 log10 CFU. Wound closure measurements and histology
analysis of biopsies obtained from the combinational therapy group indicated significant enhancement in the
wound healing process compared to all other groups.
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Conclusions: We demonstrated that co-administration of MSCs and Oh-LAAO into a mouse model of MRSA-
infected wounds exhibited a synergistic antibacterial effect which significantly reduced the bacterial count and
accelerated the wound healing process.
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Bacterial infection has been identified as a major causative
factor in the impairment of wound healing [1]. Methicillin-
resistant Staphylococcus aureus (MRSA) is a widespread
staphylococcal strain responsible for many local and sys-
temic infections and is known to rapidly develop resistance
towards commonly prescribed antibiotics. Consequently,
the observed prevalence and adaptation of MRSA together
with the recent appearance of vancomycin-resistant strains
has resulted in an increasing spectrum of untreatable
staphylococcal infections [2]. Therefore, novel approaches
to treat MRSA infections and counter the increasing
problem of antimicrobial resistance (AMR) are urgently
required.
Bioprospecting of therapeutic compounds from snake
venoms has identified a myriad of proteins which exhibit
antimicrobial activities. L-amino acid oxidase isolated from
Ophiophagus hannah (Oh-LAAO) has been demonstrated
to be more efficacious in its antimicrobial activity against
many strains of Gram-positive bacteria commonly associ-
ated with cutaneous wounds compared to routinely used
antibiotics [3]. The antimicrobial activity of Oh-LAAO on
MRSA has also been previously demonstrated [4], as has
properties of thermal stability and retention of activity
under alkaline conditions [5].
Mesenchymal stromal cells (MSCs) have been explored
for cutaneous wound healing as they demonstrate a high
regenerative capacity and in vivo immunomodulatory ef-
fects. Ex vivo studies with MSCs have demonstrated their
active participation in the wound healing process via a
multitude of mechanisms including angiogenesis, differen-
tiation, secretion of paracrine factors, promotion of cell
migration, re-epithelialization, restoration of sebaceous
glands and hair follicles, increased collagen deposition,
enhanced tissue granulation, a decrease in inflammatory
response, and local cell engraftment [6–9]. In addition,
administration of MSCs in infected models has been
reported to result in beneficial outcomes including eli-
citing anti-inflammatory and anti-apoptotic responses,
neoangiogenesis, immunomodulation, and activation of
resident stem cells [10]. Furthermore, MSCs have also
been demonstrated to secrete the antimicrobial peptide
(AMP) LL-37 when challenged with Escherichia coli in
an in vivo mouse pneumonia model [11]. In terms of
skin infections, MSCs introduced by intravenous tail
injection into subcutaneous MRSA-infected rats wereable to reduce the bacterial load in a dose-dependent
manner [12].
Published data have indicated that synergistic anti-
bacterial effects could be achieved by co-administration
of two or more antimicrobial agents, which may con-
sists of antibiotics [13], proteins [14], or essential oils
[15]. These combinations have been shown to enhance
antibacterial activity towards resistant and nonresistant
bacterial strains. It is suggested that compounds which
target the cell wall or cell membrane are likely to syner-
gize the effects of accompanying drugs as a result of
increased permeability [13]. However, this hypothesis
has not been proven in a cell- and protein-based com-
bination. Here, we describe, for the first time, studies of
the synergistic antibacterial effect of co-administering
MSCs and Oh-LAAO in a mouse model of MRSA-
infected cutaneous wounds. We found that there were
significant synergistic antibacterial activities when MSCs
and Oh-LAAO were co-administered in infected models
which led to substantial bacterial load reduction and en-
hanced improvements in the wound healing process.
Methods
Isolation and characterization of MSCs
MSCs were isolated as previously described [16]. Briefly,
adipose tissues were collected from subcutaneous sites
of male C57/BL6 mice and digested with 1 mg/ml
collagenase IA for 1 h at 37 °C in a shaking incubator.
The released cells were separated by centrifugation and
erythrocytes were removed from the sample using the
BD Pharm Lyse Lysing Buffer. The cells were then resus-
pended in StemXVivo™ media and maintained in a 37 °C
humidified incubator with 5% carbon dioxide. The conflu-
ent cultures were passaged and amplified until a morpho-
logically homogenous cell population was achieved.
Characterization of mouse adipose-derived MSCs
Standard characterization of MSCs was performed by
immunophenotyping of cell surface markers and differ-
entiation into adipocytes, osteocytes, and chondrocytes.
Immunophenotyping was performed using the Mouse
Mesenchymal Stem Cell Marker Antibody Panel (R&D
Systems). Flow cytometry analysis was performed using
the FACSVantage™ system and CellQuest software.
Differentiation of the MSCs into adipocytes, osteocytes,
and chondrocytes was performed using the Mouse
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(R&D Systems) [17].
Purified Oh-LAAO
The purified Oh-LAAO used in our study was a kind
gift from Sugita Kunalan, Monash University, Malaysia.
Characterization of the protein was performed by so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), Western blot, and liquid chromatography-
mass spectrometry/mass spectrometry (LCMS/MS). En-
zymatic analyses including LAAO activity, cytotoxicity,
and antibacterial assays confirmed functionality and a
minimum inhibitory concentration (MIC) value similar to
published data [4]. Purity of the enzyme was reconfirmed
by SDS-PAGE prior to in vivo studies.
In vivo study of MSC and Oh-LAAO treatment on infected
cutaneous wounds
The wound model was created using male C57/BL6 mice
aged 6 to 7 weeks old. The animals were maintained in in-
dividually ventilated cages under climate-controlled condi-
tions of 12 h light/dark cycles at 22.0 ± 3 °C. Standard
rodent chow pellets and water were provided ad libitum.
A biopsy punch was used to create a 5-mm full-thickness
excisional skin wound on the dorsal midline [18]. The
wounds were inoculated with 107 colony-forming units
(CFU) MRSA. Five treatment groups were planned: 1) co-
administration of MSCs and Oh-LAAO; 2) MSCs only; 3)
Oh-LAAO only; 4) Fusidic acid ointment (FAO); and 5)
phosphate-buffered saline (PBS) (n = 6). A parallel study
of the treatment groups was performed on uninfected
models. MSCs were administered by intradermal injec-
tions consisting of 1 × 106 cells. Oh-LAAO was adminis-
tered at a concentration of 10 mg/kg body weight. MSCs
were introduced by intradermal injection into four sites
adjacent to the wound edges. A digital calliper was used to
measure the extent of the wound size on day 0, day 3, and
day 7 of the observation period.
Enumeration of MRSA at the wound sites
Enumerations of MRSA on cutaneous samples ob-
tained from the in vivo studies were performed with
CHROMagar™ MRSA. Skin biopsies of the wound site
were homogenized and dilutions to 108 were made in PBS
before spreading onto CHROMagar plates. The inoculated
plates were incubated at 37 °C for 24 h and the CFU/ml
for each treatment group was determined.
Histopathological analyses of wound biopsies
Skin biopsy specimens obtained from each in vivo study
group were fixed in 10% (v/v) neutral-buffered formalin.
The specimens were embedded in paraffin blocks and
sliced with a microtome to 5-μm sections for subsequent
Masson’s Trichrome and hematoxylin and eosin (H&E)staining. The tissue specimens were examined by micros-
copy for determination of collagen deposition, angiogen-
esis, fibroblast proliferation, epithelialization, and tissue
granulation.
Histological scores were assigned based on a previously
published method [19]. Points allocation were determined
as follows: 1–3, absence of granulation tissue and epithe-
lial migration with minimal cell accumulation; 4–6, thin
and immature granulation tissues consisting predomin-
antly of inflammatory cells—a limited number of fibro-
blasts, blood capillaries, and collagen deposition is
observed accompanied by minimal epithelial migration;
7–9, moderately thick granulation tissues with cellular
accumulation ranging from predominantly inflammatory
cells to increasing numbers of fibroblasts and collagen
deposition—extensive neovascularization is present ac-
companied by minimal to moderate epithelium migration;
and 10–12, thick, vascular granulation tissues consisting
predominantly of fibroblasts accompanied by extensive
collagen deposition—epithelium migration has extended
to partially to completely covering the wound area.
Statistical analysis
All experimental data were expressed as mean ± stand-
ard deviation (SD). Statistical analyses were performed
by one-way analysis of variance (ANOVA) followed by
the Tukey HSD test. Values obtained which represented
p < 0.05 were considered to be statistically significant.
Results
Isolated treatment components, MSCs and Oh-LAAO,
conform to standard validation assays
MSCs isolated from the adipose tissues were heterogeneous
at passage 0 and gradually attained a uniform fibroblastic
morphology by passage 3 [16]. The immunophenotyping
results indicated the cells were positive for the stromal
markers Sca-1, CD106, CD105, CD73, CD29, and
CD44, while they were negative for CD45 and CD11b
(see Additional file 1: Figure S1) which corresponds to
published data [16]. Additionally, a differentiation assay
indicated that the isolated cells were able to transdiffer-
entiate into adipocytes, osteocytes, and chondrocytes
(see Additional file 1: Figure S2) [20].
SDS-PAGE conducted on purified Oh-LAAO revealed
a single band with a molecular weight of approximately
68 kDa (see Additional file 1: Figure S3) which corre-
sponds to data previously reported to be the expected
size of Oh-LAAO [4].
Combinational therapy of MSCs and Oh-LAAO synergistically
reduces bacterial load and reverses the wound healing delay
caused by infection
In the MRSA-infected groups, the highest healing rate
was observed for the combinational therapy of MSCs
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followed by the FAO treated group. The MSC and Oh-
LAAO individual treatment groups healed at similar
rates without any significant differences observed. The
PBS group was the slowest to heal (Figs. 1 and 2). In the
uninfected groups, the highest healing rate was observed
for the MSC individual treatment group and combin-
ational therapy of MSCs and Oh-LAAO at both day 3
and day 7. This was followed by the FAO, Oh-LAAO,
and PBS groups, which healed at similar rates without
any significant differences observed (Figs. 3 and 4).
In the MRSA enumeration study, treatment with a
standard antibiotic (FAO) resulted in the highest bacter-
ial reduction to approximately 3.5 log10 CFU. This was
followed by the combinational therapy, with a reduction
of approximately two orders of magnitude to 5.1 log10
CFU. Treatment with MSCs resulted in 6.1 log10 CFU of
surviving MRSA while the Oh-LAAO treated group re-








Fig. 1 Wound healing rate of the methicillin-resistant Staphylococcus aureu
The animals were divided into five study groups: mesenchymal stromal cel
oxidase (Oh-LAAO), MSCs only, Oh-LAAO only, Fusidic acid ointment (FAO),Treated groups indicated improvements in histopathological
assessments
Histological analyses were performed on tissue samples
obtained at the end of the 7 days in vivo study duration.
In the MRSA-infected groups, combinational therapy
with MSCs and Oh-LAAO demonstrated the most sig-
nificant improvements in all the assessed parameters
(Fig. 6). This was followed by the FAO treated group
which presented a comparable amount of collagen ac-
cumulation but moderate formation of blood capillar-
ies, fibroblast infiltration, and re-epithelialization. The
MSC and Oh-LAAO individual treatment groups dem-
onstrated similar improvements. However, the MSC
group exhibited more evident neovascularization com-
pared to the Oh-LAAO group.
In the uninfected groups, the most significant im-
provements in the assessed histological parameters were
observed in the combinational therapy and MSC treated
groups (Fig. 7). The Oh-LAAO, FAO, and PBS groupsfected
Day 3 Day 7
s (MRSA)-infected mouse cutaneous wound model at days 0, 3, and 7.
ls (MSCs) in combination with Ophiophagus hannah L-amino acid
and phosphate-buffered saline (PBS)
Fig. 2 Wound healing rate of MRSA-infected study groups consisting of mesenchymal stromal cells (MSCs) in combination with Ophiophagus hannah
L-amino acid oxidase (Oh-LAAO), MSCs only, Oh-LAAO only, Fusidic acid ointment (FAO), and phosphate-buffered saline (PBS). Measurements were
taken on days 0, 3, and 7 post-wounding to assess the efficacy of each treatment
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inclusion of MSCs. In general, it was evident that the
MRSA-infected groups demonstrated reduced improve-
ments in the histological parameters assessed compared
to the corresponding uninfected groups, indicating that
the MRSA infection produced in our study significantly
reduced healing rates of the open wounds. A summary of
the histopathological assessment of the wound healing of
infected and uninfected animal study groups is provided
in Table 1.
Discussion
Here we describe the combinational treatment of an
antimicrobial protein, Oh-LAAO, and cell replacement
therapy with MSCs which exhibit both a regenerative
capacity and antibacterial properties in the mitigation of
an MRSA-infected cutaneous wound model. Our find-
ings in the in vivo study indicated that individual treat-
ment with Oh-LAAO reduced the inoculated MRSA
load by one order of magnitude with no significant signs
of toxicity or wound closure delays in both the infected
and uninfected models. There was also no observed de-
terioration in the histological findings and, therefore,
Oh-LAAO could be classified as a relatively safe protein
drug with the potential to be developed as a therapeutic
candidate. To the best of our knowledge, snake venom
LAAOs have not been investigated in vivo as an antibac-
terial agent. Although research into the antimicrobial
activity of snake venom LAAOs is abundant [21], much
of the work has focused on in vitro research. In a similar
animal study, Crotalus adamanteus toxin II (CaTx-II)isolated from the venom of Crotalus adamanteus was
used as an antibacterial agent to investigate its effects on a
Staphylococcus aureus-infected mouse cutaneous wound
model [22]. Comparatively, it was noted that an in vitro
antibacterial assay of both Oh-LAAO and CaTx-II indi-
cated similar MIC and minimum bactericidal concentra-
tion (MBC) values. However, in the in vivo study it was
found that Oh-LAAO exerted a lower antibacterial effect
compared to CaTx-II, as demonstrated by the end-point
bacterial CFU enumeration. This observation could be
partly explained by the size and stability of the isolated en-
zymes, as it is not uncommon for the half-life of different
proteins to vary in vivo based on these characteristics. As
degradation of the enzymes progresses, possible structural
and functional loss may occur. It is postulated that Oh-
LAAO may be more susceptible to the effects of func-
tional loss as it exerts its antibacterial activity by hydrogen
peroxide release (requiring an intact catalytic site) which
may be compromised by early in vivo degradation of the
protein. The mechanism of action of CaTx-II differs from
Oh-LAAO and may not be as severely affected by the
in vivo microenvironment, and therefore may have pro-
longed its antibacterial effect.
In comparison to the Oh-LAAO group, the adminis-
tration of MSCs in the infected model demonstrated a
similar reduction in bacterial burden of one order of
magnitude accompanied by a comparable wound closure
rate. Histological assessments also revealed similar im-
provements, except that the MSC group indicated higher
formation of blood capillaries. These results collectively
demonstrated that reduction of bacterial burden led to
Uninfected







Fig. 3 Wound healing rate of the uninfected mouse cutaneous wound model at days 0, 3, and 7. The animals were divided into five study
groups: mesenchymal stromal cells (MSCs) in combination with Ophiophagus hannah L-amino acid oxidase (Oh-LAAO), MSCs only, Oh-LAAO only,
Fusidic acid ointment (FAO), and phosphate-buffered saline (PBS)
Mot et al. Stem Cell Research & Therapy  (2017) 8:5 Page 6 of 11tandem improvements in the wound healing process. It
has previously been demonstrated that human MSCs se-
crete the AMP LL-37 when challenged with bacteria,
which accounts for its direct antimicrobial activity [11].
Therefore, it is postulated that the mouse homolog of
LL-37, mCRAMP (mouse cathelicidin-related antimicro-
bial peptide) [23], was secreted in response to the pres-
ence of MRSA in our study leading to the reduction in
bacterial count. In addition, previous studies have dem-
onstrated that MSCs may participate in the mitigation of
infection by secretion of soluble paracrine factors includ-
ing interleukin (IL)-10 [24], prostaglandin E2 (PGE2)
[25], tumor necrosis factor (TNF)-α-stimulated gene/
protein 6 [26], and IL-6 [27]. A previous study investi-
gating the antibacterial effects of MSCs on a subcutane-
ous infected rat model indicated a higher reduction of
MRSA count compared to our present findings [12].
This observation could be explained by the amount of
cells administered into the host animals. In the present
investigation, 1 × 106 MSCs were introduced once byintradermal route at the beginning of the study, while the
dosing regimen of the previous study was by intravenous
injection once a day for 4 days with MSC concentrations
varying from 2 × 105 to 2 × 107 cells per animal. Their
findings indicated that all cell concentrations used re-
sulted in a lower CFU count compared to our study. As
such, improvements to our present research design could
be made by incorporation of additional MSC doses and
administering higher concentrations of cells.
Furthermore, it was observed that the combinational
therapy of MSCs and Oh-LAAO in our study demon-
strated greater in vivo antibacterial activity by reducing
the MRSA load in the infected model by two orders of
magnitude. These results suggest that a synergistic effect
was produced by administration of the treatments in
combination. To the best of our knowledge, this is the
first study to demonstrate that a protein and cell com-
binational therapy is able to produce synergistic anti-
microbial activity. In vitro synergies by antibacterial
proteins have been observed by treatment combinations
Fig. 4 Wound healing rate of uninfected study groups consisting of mesenchymal stromal cells (MSCs) in combination with Ophiophagus hannah
L-amino acid oxidase (Oh-LAAO), MSCs only, Oh-LAAO only, Fusidic acid ointment (FAO), and phosphate-buffered saline (PBS). Measurements were
taken on days 0, 3, and 7 post-wounding to assess the in vivo toxicity of each treatment
Fig. 5 Wound biopsies of methicillin-resistant Staphylococcus aureus (MRSA)-infected study groups were homogenized and plated on CHROMagar for
enumeration of mauve colonies. All treatment groups demonstrated reduction of bacterial load compared to the untreated (phosphate-buffered saline;
PBS) control. The most significant reduction was observed in the standard antibiotic group (Fusidic acid ointment; FAO). In the experimental therapy
groups, the mesenchymal stromal cells (MSCs) and Ophiophagus hannah L-amino acid oxidase (Oh-LAAO) combinational treatment resulted in the
highest reduction of MRSA count, by approximately two orders of magnitude. MRSA enumeration of the study groups with individual treatment of
MSCs and Oh-LAAO indicated a reduction of one order of magnitude compared to the untreated control
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Fig. 6 Histological evaluation of MRSA-infected wound biopsies
stained with H&E (a–e) and Masson’s trichrome (f–j). Treatments
were performed with combinational therapy of MSCs and Oh-LAAO
(a, f), MSCs (b, g), Oh-LAAO (c, h), FAO (d, i), and PBS (e, j). bc blood
capillaries, co collagen fibers, ep epithelialization, F fibroblast
Fig. 7 Histological evaluation of uninfected wound biopsies stained
with H&E (a–e) and Masson’s trichrome (f–j). Treatments were performed
with combinational therapy of MSCs and Oh-LAAO (a, f), MSCs (b, g),
Oh-LAAO (c, h), FAO (d, i), and PBS (e, j). bc blood capillaries, co collagen
fibers, ep epithelialization, F fibroblast
Table 1 Wound area assessment at days 3 and 7 of in vivo
study and histopathological scores of healing parameters
performed on biopsy samples sectioned and stained by
hematoxylin and eosin and Masson’s trichrome
% Wound area
Treatment Histological score Day 3 Day 7
MRSA-infected
MSCs and Oh-LAAO 9.8 ± 0.6 65.8 ± 3.8 43.3 ± 3.2
MSCs 6.1 ± 0.5 82.1 ± 2.1 57.8 ± 2.2
Oh-LAAO 5.7 ± 0.3 83.9 ± 2.3 58.9 ± 2.1
FAO 6.4 ± 0.3 75.5 ± 2.5 51.9 ± 2.1
PBS 3.7 ± 0.4 91.3 ± 2.9 65.3 ± 3.1
Uninfected
MSCs and Oh-LAAO 11.3 ± 0.5 58.9 ± 3.8 40.1 ± 3.2
MSCs 11.5 ± 0.3 55.6 ± 3.9 38.9 ± 4.2
Oh-LAAO 6.6 ± 0.7 74.1 ± 4.8 51.5 ± 3.9
FAO 6.7 ± 0.5 73.3 ± 4.5 50.9 ± 3.7
PBS 6.9 ± 0.4 71.8 ± 4.7 50.3 ± 3.5
FAO Fusidic acid ointment, MSCs mesenchymal stromal cells, Oh-LAAO
Ophiophagus hannah L-amino acid oxidase, PBS phosphate-buffered saline
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against Staphylococcus aureus and Escherichia coli [14].
Aside from the reduction in bacterial burden, marked
improvements were also observed in the wound closure
rate and histological analyses, meaning that the combin-
ational therapy was able to substantially accelerate the
wound healing process compared to the individual treat-
ments and controls. Further detailed analysis of the bac-
terial enumeration results revealed that the combined
treatment effectively reduced the MRSA count to the ap-
proximate range of 105 CFU, which was demonstrated in
our optimization procedures to be insufficient to cause
significant delays in wound closure. This finding corrob-
orates with our wound measurement and histological
assessment which indicated a marginal difference be-
tween the infected and uninfected wounds treated with
the combinational therapy. From this finding, it could be
postulated that reduction of bacterial burden to below
its critical level to manifest infection could negate the
delay in wound healing, and that total eradication of
bacterial presence in open wounds may not be necessary
for the resumption of normal wound closure to take
Fig. 8 Proposed mechanism of synergistic antibacterial activity by
combinational therapy of Oh-LAAO and mCRAMP. In the attachment
phase, the treatment components, Oh-LAAO and mCRAMP,
recognize and bind to the surface of MRSA. During the reaction
phase, Oh-LAAO catalyses the oxidative deamination of L-amino
acids into its corresponding keto acids with the release of hydrogen
peroxide as a by-product, while mCRAMP reacts with the bacterial
surface membrane leading to pore formation. Finally, in the entry
phase the generated hydrogen peroxide enters the bacterial cells via
mCRAMP-formed pores, leading to disruption of multiple intracellular
component targets including proteins and DNA, subsequently causing
more rapid cell lysis
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data of human studies which have indicated that a crit-
ical level of bacteria of between 104 to 106 CFU must be
reached to cause infection [28].
The mechanisms of synergistic antimicrobial activities
are not well understood. In general, synergistic activities
are observed in antimicrobial drug combinations which
act via different mechanisms and, in some cases, one
treatment component involves a membrane targeting
agent which often increases permeability [13]. It has been
elucidated that the mechanism of mCRAMP antimicrobial
activity involves binding on the bacterial surface to per-
meablize cells leading to loss of cytoplasmic content [23].
The enzymatic reaction of Oh-LAAO oxidizes L-amino
acids to their corresponding keto acid with hydrogen per-
oxide released as a by-product; this has been proposed to
be responsible for its bactericidal effects [3]. Additionally,
Oh-LAAO has been demonstrated to bind to both Gram-
positive and -negative bacterial surfaces, leading to high
local concentrations of hydrogen peroxide which increases
its antibacterial potency. The presence of mCRAMP
which permeabilizes bacterial membranes could facilitate
the entry of liberated hydrogen peroxide into the cyto-
plasm of pathogens leading to disruption of multiple intra-
cellular component targets including proteins and DNA,
subsequently causing more rapid cell lysis (Fig. 8).
AMPs are known to increase the permeability of bacter-
ial membranes to synergize with conventional antibiotics
[29]. Chimeric AMPs synthesized by combinations of
functional groups from natural AMPs have demonstrated
synergistic effects with conventional antibiotics includ-
ing cefotaxime, ciprofloxacin, and erythromycin [30].
The synergistic effect observed in our study suggests
that mCRAMP may contribute to boosting antibacterial
activity by combinations with other antibiotics and
antimicrobial proteins. Additionally, it is postulated
that co-administrations with mCRAMP may not result
in adverse effects related to drug-drug interactions or
interference with antibacterial activity, considering it is
an endogenous protein.
While some novel antibacterial proteins may perform
well in vitro, problems with toxicity may limit their
potential clinical application. In such instances, the com-
pound may be salvaged by the use of an enhancer which
synergizes with its effects, leading to a reduced dose
required to achieve therapeutic efficacy and thereby pre-
venting toxicity. This could be achieved with the use of a
membrane permeabilizing AMP such as mCRAMP. It is
therefore postulated that AMPs with this function may be
used to reduce the administration dose of antibacterial
proteins isolated from novel sources such as snake
venoms which are highly efficacious towards pathogenic
bacteria including resistant strains, but also exhibit high
toxicity towards eukaryotic cells. LAAOs, phospholipaseA2, and cathelicidins are included among the many prom-
ising antibacterial proteins that have been identified from
snake venoms [31] which are efficacious against clinically
important Gram-positive and Gram-negative bacteria.
Therefore, co-administration with MSCs or mCRAMP
may be a feasible solution to broadening the spectrum of
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ant bacteria.
Conclusions
In conclusion, combinational therapy of MSCs and Oh-
LAAO may be useful in the treatment of MRSA-
infected cutaneous wounds as demonstrated by the
mitigation of wound healing and synergistic antibacter-
ial activity. Additionally, mCRAMP secretion by MSCs
could also be explored for synergistic effects with con-
ventional antibiotics and for reducing the dose of novel
antimicrobial agents which exhibit high toxicity.
Additional file
Additional file 1: Figure S1. Flow cytometry analysis of MSCs isolated
from mouse adipose tissues at passage 3. The data obtained correspond
to currently reported phenotype of MSCs which are positive for Sca-1,
CD106, CD105, CD73, CD29, and CD44, while negative for CD45 and
CD11b. Figure S2. Cellular morphology and staining of MSC differenti-
ation assay. MSCs were incubated for 14 days for adipogenic differenti-
ation and 21 days for chondrogenic and osteogenic differentiation.
Differentiation of MSCs was confirmed with Oil Red O for adipocytes, Ali-
zarin Red for osteocytes, and Safranin O for chondrocytes. The negative
controls consisted of undifferentiated MSCs stained with either Oil Red O,
Alizarin Red, or Safranin O in the corresponding assays. All images are of
10× magnification except for Oil Red O stained adipocytes and Safranin
O stained chondrocytes which are of 20× magnification. Scale bars =
50 μm. Figure S3. SDS-PAGE performed on the expected Oh-LAAO frac-
tion isolated from two-step Mono Q ion exchange chromatography and
BioSep-Sec-S size exclusion chromatography. Standard 4% stacking gel
and 12% resolving gel was used in the procedure. The results indicated
the presence of a single protein band, denoting the protein has been
purified to homogeneity. (DOCX 731 kb)
Abbreviations
AMP: Antimicrobial peptide; AMR: Antimicrobial resistance; CaTx-II: Crotalus
adamanteus toxin II; CFU: Colony-forming units; FAO: Fusidic acid ointment;
H&E: Hematoxylin and eosin; LCMS: Liquid chromatography-mass
spectrometry; MBC: Minimum bactericidal concentration; mCRAMP: Mouse
cathelicidin-related antimicrobial peptide; MIC: Minimum inhibitory
concentration; MRSA: Methicillin-resistant Staphylococcus aureus;
MSC: Mesenchymal stromal cell; Oh-LAAO: Ophiophagus hannah L-amino
acid oxidase, PBS, Phosphate-buffered saline; SDS-PAGE: Sodium dodecyl
sulfate polyacrylamide gel electrophoresis
Acknowledgements
We would like to acknowledge the Malaysian Ministry of Higher Education
(MOHE), the Tropical Medicine and Biology: Infectious Disease and Health
Platform of Monash University, Malaysia for providing research funding, and
the Head of School and administration staff of the Jeffrey Cheah School of
Medicine for their continuous support to this project.
Funding
This research was funded by the Exploratory Research Grant Scheme (ERGS)
1/2011/STG/MUSM/03/5 provided by the Malaysian Ministry of Higher
Education (MOHE).
Availability of data and materials
Not applicable.
Authors’ contributions
MYY conducted the experiments and wrote the manuscript. IO and SSH
analyzed and interpreted the data, and revised the manuscript for publication.
All authors read and approved the publication of the manuscript.Competing interests
The authors declare that they have no competing interests.
Consent for publication
All authors consent to the publication of this manuscript.
Ethics approval
Animal ethics approval for this research project has been obtained from the
Monash University Animal Ethics Committee (AEC). The AEC reference
number is MARP/2012/037. The study conducted complied with all standard
institutional ethical guidelines for animal care and experimentation provided
by the approving committee.
Received: 7 October 2016 Revised: 9 December 2016
Accepted: 14 December 2016
References
1. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis.
2004;17:91–6.
2. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B,
et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl
J Med. 1999;340:493–501.
3. Lee ML, Tan NH, Fung SY, Shamala DS. Antibacterial action of a heat-stable
form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah)
venom. Comp Biochem Physiol C Toxicol Pharmacol. 2011;153:237–42.
4. Phua CS, Vejayan J, Ambu S, Ponnudurai G, Gorajana A. Purification and
antibacterial activities of an L-amino acid oxidase from king cobra (Ophiophagus
hannah) venom. J Venom Anim Toxins incl Trop Dis. 2012;18:198–207.
5. Tan NH, Saifuddin MN. Isolation and characterization of an unusual form of
L-amino acid oxidase from cobra (Ohpiophagus hannah) venom. Biochem
Int. 1989;19:937–44.
6. Kataoka K, Medina RJ, Kageyama T, Miyazaki M, Yoshino T, Makino T, et al.
Participation of adult mouse bone marrow cells in reconstitution of skin.
Am J Pathol. 2003;163:1227–31.
7. Li H, Fu X, Ouyang Y, Cai C, Wang J, Sun T. Adult bone-marrow-derived
mesenchymal stem cells contribute to wound healing of skin appendage.
Cell Tissue Res. 2006;326:725–36.
8. Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, et al. Kidney-derived
mesenchymal stem cells contribute to vasculogenesis, angiogenesis and
endothelial repair. Kidney Int. 2008;74:879–89.
9. Borena BM, Pawde AM, Amarpal AHP, Kinjavdekar P, Singh R, et al.
Evaluation of autologous bone marrow-derived nucleated cells for healing
of full-thickness skin wounds in rabbits. Int Wound J. 2010;7:249–60.
10. Wannemuehler TJ, Manukyan MC, Brewster BD, Rouch J, Poynter JA, Wang
Y, et al. Advances in mesenchymal stem cell research in sepsis. J Surg Res.
2012;173:113–26.
11. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al.
Antibacterial effect of human mesenchymal stem cells is mediated in part
from secretion of the antimicrobial peptide LL-37. Stem Cells. 2010;28:2229–38.
12. Yuan Y, Lin S, Guo N, Zhao C, Shen S, Bu X, et al. Marrow mesenchymal
stromal cells reduce methicillin-resistant Staphylococcus aureus infection in
rat models. Cytotherapy. 2014;16:56–63.
13. Hu Y, Coates AR. Enhancement by novel anti-methicillin-resistant
Staphylococcus aureus compound HT61 of the activity of neomycin,
gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies.
J Antimicrob Chemother. 2013;68:374–84.
14. Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, et al. Synergistic
effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and
lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci.
2005;40:123–32.
15. Bassolé IH, Juliani HR. Essential oils in combination and their antimicrobial
properties. Molecules. 2012;17:3989–4006.
16. Sung JH, Yang HM, Park JB, Choi GS, Joh JW, Kwon CH, et al. Isolation and
characterization of mouse mesenchymal stem cells. Transplant Proc.
2008;40:2649–54.
17. Sowa Y, Imura T, Numajiri T, Nishino K, Fushiki S. Adipose-derived stem cells
produce factors enhancing peripheral nerve regeneration: influence of age
an anatomic site of origin. Stem Cells Dev. 2012;21:1852–62.
18. Chen LW, Tredget EE, Liu CX, Wu YJ. Analysis of allogenicity of
mesenchymal stem cells in engraftment and wound healing in mice. PLoS
One. 2009;4:e7119.
Mot et al. Stem Cell Research & Therapy  (2017) 8:5 Page 11 of 1119. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate
wound healing in the genetically diabetic mouse. Am J Pathol.
1990;136:1235–46.
20. Zhu X, Du J, Liu G. The comparison of multilineage differentiation of
bone marrow and adipose-derived mesenchymal stem cells. Clin Lab.
2012;58:897–903.
21. Izidoro LF, Sobrinho JC, Mendes MM, Costa TR, Grabner AN, Rodrigues VM,
et al. Snake venom L-amino acid oxidases: trends in pharmacology and
biochemistry. Biomed Res Int. 2014;2014:196754.
22. Samy RP, Kandasamy M, Gopalakrishnakone P, Stiles BG, Rowan EG, Becker
D, et al. Wound healing activity and mechanisms of action of an
antibacterial protein from the venom of the eastern diamondback
rattlesnake (Crotalus adamanteus). PLoS One. 2014;9:e80199.
23. Yu K, Park K, Kang SW, Shin SY, Hahm KS, Kim Y. Solution structure of a
cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR
spectroscopy. J Pept Res. 2002;60:1–9.
24. Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M.
Human adult stem cells derived from adipose tissue protect against
experimental colitis and sepsis. Gut. 2009;58:929–39.
25. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al.
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-
dependent reprogramming of host macrophages to increase their
interleukin-10 production. Nat Med. 2009;15:42–9.
26. Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, Coble K, et al. Action at a
distance: Systemically administered adult stem/progenitor cells (MSCs)
reduce inflammatory damage to the cornea without engraftment and
primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells.
2011;29:1572–9.
27. Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F,
et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a
model for neutrophil preservation in the bone marrow niche. Stem Cells.
2008;26:151–62.
28. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated
approaches to wound management. Clin Microbiol Rev. 2001;14:244–69.
29. Coates A, Hu Y. Conventional antibiotics—revitalized by new agents. In:
Phoenix DA, Harris F, Dennison SR, editors. Novel antimicrobial agents and
strategies. Weinheim: Wiley-VCH; 2014. p. 17–30.
30. Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, et al. Synergistic effects
and anti-biofilm properties of chimeric peptides against MDR Acinetobacter
baumannii strains. Antimicrob Agents Chemother. 2014;58:1622–9.
31. Samy RP, Gopalakrishnakone P, Satyanarayanajois SD, Stiles BG, Chow VTK.
Snake venom proteins and peptides as novel antibiotics against microbial
infections. Curr Proteomics. 2013;10:10–28.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
